Demonstrates high hydrogen generation rates in NaBH₄ hydrolysis with Ru/TiO₂ nanocomposites and reveals their antimicrobial effectiveness.
Herein, Ru⁰/TiO₂ nanocomposites containing 0.5 wt% Ru were prepared via a simple wet-impregnation route followed by chemical reduction and were thoroughly characterized by XRD, FTIR, SEM, TEM, and EDS analyses. The nanocomposite exhibits high activity toward the hydrolysis of NaBH₄ in water under relatively mild conditions (300 mM NaBH₄, without added base). Systematic variation of NaBH₄ concentration and catalyst loading shows that the hydrogen generation rate is essentially first order in both NaBH₄ and Ru⁰/TiO₂, yielding hydrogen generation rates in the range of ≈ 335.6 mL·min⁻¹·g_cat⁻¹ and turnover frequencies (TOF) of ≈ 938.30 h⁻¹ between 25 and 40 °C. Temperature-dependent kinetic measurements afforded an apparent activation energy of 32.37 kJ·mol⁻¹ together with ΔH‡ = 29.82 kJ·mol⁻¹ and ΔS‡ = -143 J·mol⁻¹·K⁻¹, indicating an energetically accessible yet highly ordered transition state at the Ru/TiO₂ interface. The catalyst retains ~ 36% activity after 4 cycles. In addition, Ru⁰/TiO₂ nanocomposites display strong antibacterial activity against both Gram-positive and Gram-negative bacteria, achieving growth inhibition above 90% at 500 µg·mL⁻¹. The dual functionality of Ru⁰/TiO₂ in highly efficient NaBH₄ hydrolysis and pronounced antimicrobial behavior highlights this nanocomposite as a versatile platform for practical chemical hydrogen storage and integrated energy and environmental applications.
No takes yet. Share an insight, caveat, or question.
Halvacı et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: